CARDIFF ONCOLOGY, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
CARDIFF ONCOLOGY, INC. (CRDF) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$5.27 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2019-08-08
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-06-30 was $0.00.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-03-31 was -$5.27K.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-09-30 was $59.44K.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2018 was $22.84K, a 99.90% decline from fiscal 2017.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $23.96M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$24.83M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$2.23M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 152 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 155 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 158 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 161 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 164 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 167 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 170 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 173 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$5.27K 10-Q · filed 2019-08-08 | -$5.27K derived: sum of 3 quarters · filed 2019-08-08 | $54.17K derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2019-03-31 | -$5.27K 10-Q · filed 2019-05-07 | -$5.27K derived: sum of 2 quarters · filed 2019-05-07 | $54.17K derived: sum of 3 quarters · filed 2019-05-07 | $22.67K derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $59.44K derived: sum of 2 quarters · filed 2019-03-06 | $27.94K derived: sum of 3 quarters · filed 2019-08-08 | $22.84K 10-K · filed 2019-03-06 | |||||||||
| 2018-09-30 | $59.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $27.94K derived: sum of 2 quarters · filed 2019-08-08 | $22.84K 10-Q · filed 2018-11-07 | $59.53K derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2018-06-30 | -$31.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$36.60K 10-Q · filed 2019-08-08 | $90.00 derived: sum of 3 quarters · filed 2019-08-08 | -$115.42K derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2018-03-31 | -$5.10K 10-Q · filed 2019-05-07 | $31.59K derived: sum of 2 quarters · filed 2019-05-07 | -$83.92K derived: sum of 3 quarters · filed 2019-05-07 | $18.77M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||
| 2017-12-31 | $36.69K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$78.82K derived: sum of 2 quarters · filed 2019-03-06 | $18.78M derived: sum of 3 quarters · filed 2019-03-06 | $23.96M 10-K · filed 2019-03-06 | |||||||||
| 2017-09-30 | -$115.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $18.74M derived: sum of 2 quarters · filed 2018-11-07 | $23.93M 10-Q · filed 2018-11-07 | $24.34M derived: sum of 4 quarters · filed 2018-11-07 | |||||||||
| 2017-06-30 | $18.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $24.04M 10-Q · filed 2018-08-03 | $24.46M derived: sum of 3 quarters · filed 2018-08-03 | $27.83M derived: sum of 4 quarters · filed 2018-08-03 | |||||||||
| 2017-03-31 | $5.18M 10-Q · filed 2018-05-08 | $5.60M derived: sum of 2 quarters · filed 2018-05-08 | $8.97M derived: sum of 3 quarters · filed 2018-05-08 | -$19.30M derived: sum of 4 quarters · filed 2018-05-08 | |||||||||
| 2016-12-31 | $415.74K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $3.79M derived: sum of 2 quarters · filed 2018-02-26 | -$24.48M derived: sum of 3 quarters · filed 2018-02-26 | -$24.83M 10-K · filed 2018-02-26 | |||||||||
| 2016-09-30 | $3.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$24.90M derived: sum of 2 quarters · filed 2017-11-09 | -$25.25M 10-Q · filed 2017-11-09 | -$26.23M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||
| 2016-06-30 | -$28.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$28.62M 10-Q · filed 2017-08-09 | -$29.60M derived: sum of 3 quarters · filed 2017-08-09 | -$30.17M derived: sum of 4 quarters · filed 2017-08-09 | |||||||||
| 2016-03-31 | -$352.02K 10-Q · filed 2017-05-10 | -$1.33M derived: sum of 2 quarters · filed 2017-05-10 | -$1.90M derived: sum of 3 quarters · filed 2017-05-10 | -$2.34M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||
| 2015-12-31 | -$976.48K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$1.55M derived: sum of 2 quarters · filed 2017-03-15 | -$1.99M derived: sum of 3 quarters · filed 2017-03-15 | -$2.23M 10-K · filed 2017-03-15 | |||||||||
| 2015-09-30 | -$569.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$1.01M derived: sum of 2 quarters · filed 2016-11-09 | -$1.26M 10-Q · filed 2016-11-09 | -$1.32M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-06-30 | -$440.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$687.97K 10-Q · filed 2016-08-04 | -$752.13K derived: sum of 3 quarters · filed 2017-03-15 | -$854.10K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-03-31 | -$247.10K 10-Q · filed 2016-05-10 | -$311.26K derived: sum of 2 quarters · filed 2017-03-15 | -$413.23K derived: sum of 3 quarters · filed 2017-03-15 | -$428.38K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2014-12-31 | -$64.17K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$166.13K derived: sum of 2 quarters · filed 2017-03-15 | -$181.28K derived: sum of 3 quarters · filed 2017-03-15 | -$299.79K 10-K · filed 2017-03-15 | |||||||||
| 2014-09-30 | -$101.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$117.12K derived: sum of 2 quarters · filed 2015-11-09 | -$235.62K 10-Q · filed 2015-11-09 | -$313.81K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-06-30 | -$15.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$133.66K 10-Q · filed 2015-08-10 | -$211.84K derived: sum of 3 quarters · filed 2016-03-10 | -$422.80K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-03-31 | -$118.51K 10-Q · filed 2015-05-05 | -$196.69K derived: sum of 2 quarters · filed 2016-03-10 | -$407.65K derived: sum of 3 quarters · filed 2016-03-10 | -$674.44K derived: sum of 4 quarters · filed 2016-03-10 | -$1.39M 10-Q · filed 2014-05-12 | ||||||||
| 2013-12-31 | -$78.19K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$289.15K derived: sum of 2 quarters · filed 2016-03-10 | -$555.93K derived: sum of 3 quarters · filed 2016-03-10 | -$649.28K 10-K · filed 2016-03-10 | -$1.27M 10-K · filed 2014-03-17 | ||||||||
| 2013-09-30 | -$210.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$477.75K derived: sum of 2 quarters · filed 2014-11-06 | -$571.10K 10-Q · filed 2014-11-06 | -$628.96K derived: sum of 4 quarters · filed 2015-03-12 | -$1.19M 10-Q · filed 2013-11-14 | ||||||||
| 2013-06-30 | -$266.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$360.14K 10-Q · filed 2014-08-07 | -$418.00K derived: sum of 3 quarters · filed 2015-03-12 | -$489.25K derived: sum of 4 quarters · filed 2015-03-12 | -$979.22K 10-Q · filed 2013-08-14 | ||||||||
| 2013-03-31 | -$93.35K 10-Q · filed 2014-05-12 | -$151.21K derived: sum of 2 quarters · filed 2015-03-12 | -$222.46K derived: sum of 3 quarters · filed 2015-03-12 | -$265.42K derived: sum of 4 quarters · filed 2015-03-12 | -$712.43K 10-Q · filed 2013-05-14 | ||||||||
| 2012-12-31 | -$57.86K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$129.11K derived: sum of 2 quarters · filed 2015-03-12 | -$172.07K derived: sum of 3 quarters · filed 2015-03-12 | -$270.08K 10-K · filed 2015-03-12 | -$619.08K 10-K · filed 2013-04-01 | ||||||||
| 2012-09-30 | -$71.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$114.21K derived: sum of 2 quarters · filed 2013-11-14 | -$212.22K 10-Q · filed 2013-11-14 | -$212.22K derived: sum of 4 quarters · filed 2014-03-17 | -$561.22K 10-Q · filed 2012-11-14 | ||||||||
| 2012-06-30 | -$42.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$140.97K 10-Q · filed 2013-08-14 | -$140.97K derived: sum of 3 quarters · filed 2014-03-17 | -$140.97K derived: sum of 4 quarters · filed 2014-03-17 | -$489.97K 10-Q · filed 2012-08-14 | ||||||||
| 2012-03-31 | -$98.01K 10-Q · filed 2013-05-14 | -$98.01K derived: sum of 2 quarters · filed 2014-03-17 | -$98.01K derived: sum of 3 quarters · filed 2014-03-17 | -$98.01K derived: sum of 4 quarters · filed 2014-03-17 | -$447.01K 10-Q · filed 2012-05-15 | ||||||||
| 2011-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $1.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 derived: sum of 3 quarters · filed 2014-03-17 | -$1.53K 10-K · filed 2014-03-17 | |||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$1.00 derived: sum of 2 quarters · filed 2012-11-14 | -$1.53K 10-Q · filed 2012-11-14 | ||||||||||
| 2011-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$1.53K 10-Q · filed 2012-08-14 | |||||||||||
| 2011-03-31 | -$1.53K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |